September 22, 2026
Yale University and Biohaven Therapeutics Ltd. have requested attorney fees topping $23.1 million, plus $2 million each in exemplary damages, after winning a $4 million trial verdict, though both entities are also seeking a new trial to readdress damages on trade secrets and contract breach claims.
July 30, 2026
Attorneys from Susman Godfrey LLP said this week they helped secure a recent $3 million jury award in Delaware federal court for Yale University in a trade secret misappropriation case by keeping their trial strategy focused on "common sense" issues.
July 27, 2026
A Delaware federal jury has awarded Yale University and Biohaven Therapeutics $4 million after finding that venture capital firm RA Capital Management GP breached a confidentiality agreement and, along with co-defendant Avilar Therapeutics, misappropriated a Yale-developed trade secret for designing protein-degrading drug molecules.